Delivery Order SPE2DB20D3303-SPE2DB25FA2QS
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 16, 2025, for the supply of CAPLYTA 42 mg capsules in a quantity of 30 units. This firm fixed price delivery order, valued at $29,358.50 with an ultimate completion date of September 17, 2025, represents a non-set-aside competitive award. The contract will be performed at the awardee's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $3,351.92 to AmerisourceBergen Drug Corp for CAPLYTA 42 mg capsules (30-count units) on August 6, 2025, with an ultimate completion date of August 7, 2025. This is a firm fixed-price, non-set-aside contract to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $2,060.57 for 30-count bottles of CAPLYTA 42 mg capsules, an atypical antipsychotic medication. The contract, awarded on June 4, 2025, with an ultimate completion date of June 5, 2025, was competitively awarded without set-aside restrictions through a Firm Fixed Price delivery order structure. The Defense Logistics Agency, operating under the Department of Defense, is the funding...
- The Defense Logistics Agency awarded a delivery order valued at $9,468.39 to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of CAPLYTA 21 mg capsules (30-count units). This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order with an ultimate completion date of September 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,993.77 firm fixed-price delivery order is for the supply of CAPLYTA 21 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of January 16, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- The Defense Logistics Agency awarded a $10.7K delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Caplyta 42 mg capsules (30-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract will be completed by May 9, 2025, and the pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $11,458.54 to AmerisourceBergen Drug Corp for CAPLYTA 42 MG capsules (30-unit supply). The contract is firm fixed price with no set-aside designation and is scheduled for completion by September 18, 2025. This delivery order represents a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that...
- This federal contract award was issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA) Troop Support. The contract, valued at $2,261.22, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of CAPLYTA 42 MG CAPSULE 30S. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is August 22, 2024. This award is not associated with a set-aside program. As a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,916.22 Firm Fixed Price delivery order is for the supply of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of November 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,252.05 firm fixed-price delivery order contract is for the provision of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of April 2, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA2QSDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 15, 2025, by the Defense Logistics Agency (DLA) for CAPLYTA 42 mg capsules (30-count units) with a ceiling value of $5,794.03. This non-competitive delivery order is structured as a firm fixed-price contract with an ultimate completion date of August 18, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion and extending through December 2026, which serves as the company's primary vehicle for supplying pharmaceutical products and medical supplies to military healthcare systems globally. This delivery order for CAPLYTA, a psychiatric medication, exemplifies the type of specialized pharmaceutical commodities that AmerisourceBergen routinely supplies through its DLA contract portfolio. The company's demonstrated capability to fulfill federal medical procurement needs across multiple therapeutic domains, combined with its extensive network serving the Defense Health Agency and other government healthcare systems, positions it as a critical vendor in the federal medical supply chain. All of AmerisourceBergen's reviewed contract awards with DLA have been competitively awarded with firm fixed pricing, reflecting the company's consistent ability to meet stringent federal procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 8/15/25 |